Invesco Global Small Cap Equity Fund Class A (ESMAX) is an open-end mutual fund that seeks long-term growth of capital by investing at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of small-capitalization issuers and in derivatives and other instruments that have economic characteristics similar to such securities; this includes listed equity and equity-related securities of small-cap companies issued globally. The fund maintains a diversified portfolio across sectors such as industrials (approximately 27%), technology (13%), financial services (11%), consumer cyclical (9%), and communication services (7%), with top holdings including ME Group (2.11%), Karelia Tobacco (2.01%), Asker Healthcare (1.82%), Neurones (1.74%), and Laboratorios Farmaceuticos Rovi (1.63%); geographic exposure spans the United States (46%), Japan (10%), United Kingdom (8%), France (5%), and Sweden (4%), among others. It is managed by a team including Borge Endresen (since 2002), Minkun Zhang (since 2022), and newer additions Juan Hartsfield, Michael Oliveros, and Andy Tidby (since June 2025), with total net assets of approximately $188 million and a net expense ratio of 1.48%.
Launched on August 31, 2000, and domiciled in the United States, the fund is available primarily to U.S. investors with a minimum initial investment of $1,000 and features a front-end load of 5.50%. Previously known as Invesco EQV European Small Company Fund, it focused on small-cap equities in Europe; effective August 22, 2025, the fund was renamed Invesco Global Small Cap Equity Fund, its benchmarks shifted to the MSCI ACWI Index (broad-based) and MSCI ACWI Small Cap Index (style-specific), and its strategy expanded from a European focus to a global small-cap mandate, with performance prior to that date reflecting the prior European strategy. The fund is offered by Invesco, a global investment management firm headquartered in Atlanta, Georgia.